NEW YORK CITY, NY / ACCESS Newswire / March 20, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...

Q4 2024 Earnings Call Transcript March 3, 2025 Fortrea Holdings Inc. misses on earnings expectations. Reported EPS is $0.18 EPS, expectations were $0.36. Operator: Ladies and gentlemen, thank you for ...

Fortrea Holdings Inc. (NASDAQ:FTRE – Get Free Report) has received a consensus rating of “Reduce” from the twelve analysts ...

Fortrea Holdings Inc. ( ($FTRE) ) has released its Q4 earnings. Here is a breakdown of the information Fortrea Holdings Inc. presented to its ...

Research analysts at William Blair cut their Q4 2025 earnings estimates for Fortrea in a research report issued to clients ...

Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions.

Fitch predicts a 7.3% decline in Fortrea’s revenues in 2025 and expects revenue growth to return in 2026 within the 3.0% to 4.0% range. The company’s inconsistent revenue growth and uncertain ...

Contract-research organization Fortrea Holdings will appoint Erin L. Russell to its board in connection with a cooperation agreement with activist investor Starboard Value. Starboard, which ...

Clinical research company Fortrea Holdings (NASDAQ:FTRE) will be reporting earnings tomorrow before market hours. Here’s what investors should know. Fortrea met analysts’ revenue expectations ...

Ladies and gentlemen, thank you for standing by, and welcome to Fortrea Fourth Quarter 2024 Earnings Conference Call. [Operator Instructions] Please be advised that today’s conference is being ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...